page banner

HapOnco®

mClean MRD Test

HapOnco® mClean MRD Test

产品介绍

Product Overview

HapOnco® mClean MRD Tests are a series of ctDNA-based NGS assays for detecting MRD in lung, gastrointestinal, hepatobiliary and pancreatic cancer patients who are unamenable to tumor-informed MRD testing. The tests utilize a tumor-naïve approach to detect MRD in patients’ liquid biopsies, based on a preselected gene panel that covers hotspot mutations in a tumor type-specific manner. Leveraging our proprietary LIUDUS® platform with ultra-deep sequencing, HapOnco® mClean MRD Tests are capable of detecting ultra-low-frequency MRD to inform recurrence risk for cancer patients who are unamenable to tumor-informed MRD testing.

产品优势

Product Advantages

(1) The MRD Panels designed exclusively for lung cancer patents, gastrointestinal cancer patients and hepatobiliary and pancreatic cancer patients.
(2) A more comprehensive MRD safeguard solution that includes multidimensional testing, such as targeted or immunotherapy selection and genetic risk assessment.

适用人群

Applicable Population

Patients with lung cancer, gastrointestinal cancer, hepatobiliary and pancreatic cancer who cannot obtain tissue and need MRD monitoring and recurrence risk assessment.

contact us